299 related articles for article (PubMed ID: 25881131)
1. Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma.
Zedan W; Mourad MI; El-Aziz SM; Salamaa NM; Shalaby AA
Diagn Pathol; 2015 Feb; 10():2. PubMed ID: 25881131
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 17 abnormalities in squamous cell carcinoma of the oral cavity, and its relationship with p53 and Bcl-2 expression.
Kanekawa A; Tsuji T; Oga A; Sasaki K; Shinozaki F
Anticancer Res; 1999; 19(1A):81-6. PubMed ID: 10226528
[TBL] [Abstract][Full Text] [Related]
3. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
[TBL] [Abstract][Full Text] [Related]
5. p53 Expression as a marker of microinvasion in oral squamous cell carcinoma.
Heah KG; Hassan MI; Huat SC
Asian Pac J Cancer Prev; 2011; 12(4):1017-22. PubMed ID: 21790244
[TBL] [Abstract][Full Text] [Related]
6. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.
Nylander K; Dabelsteen E; Hall PA
J Oral Pathol Med; 2000 Oct; 29(9):413-25. PubMed ID: 11016683
[TBL] [Abstract][Full Text] [Related]
7. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.
Wang X; Chen S; Chen X; Zhang C; Liang X
J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282
[TBL] [Abstract][Full Text] [Related]
8. p53-positive tumor-distant squamous epithelia of the head and neck reveal selective loss of chromosome 17.
Wolf C; Flechtenmacher C; Dietz A; Weidauer H; Abel U; Maier H; Bosch FX
Laryngoscope; 2004 Apr; 114(4):698-704. PubMed ID: 15064627
[TBL] [Abstract][Full Text] [Related]
9. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.
Dorji T; Monti V; Fellegara G; Gabba S; Grazioli V; Repetti E; Marcialis C; Peluso S; Di Ruzza D; Neri F; Foschini MP
Hum Pathol; 2015 Sep; 46(9):1275-81. PubMed ID: 26170010
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
[TBL] [Abstract][Full Text] [Related]
11. Assessment of p53 and HER-2/neu genes status and protein products in oral squamous cell carcinomas.
Stoicănescu D; Andreescu N; Belengeanu A; Meszaros N; Cornianu M
Rom J Morphol Embryol; 2013; 54(4):1107-13. PubMed ID: 24399009
[TBL] [Abstract][Full Text] [Related]
12. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
[TBL] [Abstract][Full Text] [Related]
13. Distinct nonrandom patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck.
Soder AI; Hopman AH; Ramaekers FC; Conradt C; Bosch FX
Cancer Res; 1995 Nov; 55(21):5030-7. PubMed ID: 7585547
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.
Jaafari-Ashkavandi Z; Aslani E
Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768
[TBL] [Abstract][Full Text] [Related]
15. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976
[TBL] [Abstract][Full Text] [Related]
16. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma.
Huang CF; Yu GT; Wang WM; Liu B; Sun ZJ
Int J Clin Exp Pathol; 2014; 7(9):6032-9. PubMed ID: 25337248
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
19. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
[TBL] [Abstract][Full Text] [Related]
20. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]